Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The major factors driving the growth of this market are rising incidence of cancer and prevalence of cardiovascular diseases. Further adding to the growth prospects of this market are increasing the number of ablation procedures, hospitals, surgical, ablation centers and the emergence of next-generation ablation products and technologies. Apart from these, there has been a significant improvement in the patient quality of life.
On the contrary, the growth of this market is constrained by therapeutic challenges, healthcare cost-containment measures taken in a number of developed countries, lack of properly skilled labor and reprocessing and reuse of devices in developing countries. Even though this procedure lowers the side effects, it has some disadvantages for large and bulky tissues, like bone and neck nodules, which cannot be treated with ablation. Besides, the availability of ablation treatment in remote areas is quite restricted.
Market Segmentation
The market is segmented in terms of the type, application, product, and geography. On the basis of type, it is segmented into laser/light, ultrasound, radiofrequency, electrical, microwave, cryoablation, and hydrothermal ablation technology. By application type, it is segmented into cosmetic surgery, cardiovascular disease treatment, pain management, cancer treatment, ophthalmology, gynecology, urology, orthopedics, among others. On the basis of products, the ablation technologies market is segmented into light/laser ablators, ultrasound ablators, radiofrequency ablators, electrical ablators, microwave ablators, cryoablation devices, and hydrothermal ablators. Geographically, the global ablation technologies market is segmented into North America, Asia-Pacific, Europe, and the Rest of the World. In terms of application, the cardiovascular disease treatment segment is expected to command a major share in 2017. The other important segment is the microwave ablates segment, which is estimated to grow at the highest CAGR during 2017 to 2022.
Regional/Geographic Analysis
The North America region accounts for the largest market share, followed by Europe in 2016. More than 55% of the market is based out of Canada and USA. However, Asia-Pacific is projected to have the highest growth rate during the forecast period owing to the growing focus of global market players, large population base, improving healthcare infrastructure facilities, and the rising prevalence of cancer. The rest of the World market is still at a nascent stage and is expected to grow considering the continuous rise in the prevalence rate of hypertension, cardiovascular and urological diseases.
Opportunities
The market also throws up several opportunities for the need for more advanced and innovative ablation technologies to treat cancer. According to the WHO, the number of new cancer cases is expected to increase by 70% within the next two decades. In addition to this, there is a Shift towards minimal and non-invasive medical procedures and high demand for lasers. The increase in health care spending also adds to the development of this.
Key Players
The market consists of a number of big, medium-sized, and small companies. Some of the major players in the market include Medtronic, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Biosense Webster, Inc. (U.S.), Boston Scientific Corporation (U.S.), AngioDynamics, Inc. (U.S.), CONMED Corporation (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew PLC (U.K.), and Olympus Corporation (Japan).
The report contains comprehensive analysis on:
--> Global paints and coatings Market Segments
--> Global paints and coatings Market Drivers, Restraints and Opportunities
--> Global paints and coatings Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Global paints and coatings Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Feed Software Market includes
Industry Analysis, Forecasts and Opportunity Assessment (2017-2022)
> Market Trends, Dynamics and Regulatory Framework
> Regional and Cross-segment Sales Figures
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...